Gritstone Bio Stock (NASDAQ: GRTS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 358.000 / 2.881M |
Day Range | - - - |
52 Wk Range | 0.672 - 3.330 |
Market Cap | $78.076M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 9.57% |
Days to Cover | 6.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gritstone Bio (NASDAQ: GRTS) through any online brokerage.
Other companies in Gritstone Bio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by JMP Securities on Tuesday, April 2, 2024. The analyst firm set a price target for 5.00 expecting GRTS to rise to within 12 months (a possible 581.38% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Gritstone Bio (NASDAQ: GRTS) is $0.7338 last updated Today at April 23, 2024 at 5:19 AM EDT.
There are no upcoming dividends for Gritstone Bio.
Gritstone Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Gritstone Bio.
Gritstone Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.